Minister for Enterprise, Trade and Employment, Micheál Martin TD this month announced a research collaboration between the National Institute for Bioprocessing Research and Training (NIBRT) and Eli Lilly’s Biologics Research and Development Organisation (BR&D) in Indianapolis. The collaboration will involve the co-development of analytical technologies to enable the monitoring of cell culture conditions.
The announcement was made at the foundation-laying ceremony of the Eli Lilly’s new Biopharmaceuticals Manufacturing facility at its premises in Dunderrow, Kinsale, Co Cork.
NIBRT is a world-class institute that provides training and research solutions for the bioprocessing industry in state of the art facilities located in UCD, Belfield. Funded by IDA Ireland, NIBRT is based on an innovative collaboration between University College Dublin, Trinity College Dublin, Dublin City University and Institute of Technology Sligo.
Minister Martin commented “In 2005, IDA determined that if Ireland was to continue to compete for international large-scale biopharmaceutical investments, there was a strategic competitive need to establish a state of the art industry-focused centre in Biomanufacturing and Bioprocessing technology, education, training and research. NIBRT was established to fulfill this need.”
The Minister concluded “The purpose of NIBRT is to give Ireland a competitive advantage and act as a magnet of attraction for further significant investment in the biopharmaceutical industry in Ireland from both overseas and indigenous companies. This collaboration with Eli Lilly is an example of what was envisioned for NIBRT and we are looking forward to witnessing the fruits of this partnership as it progresses.”
Related Links:
